1-4 of 4
P.L. Zinzani
Close
Sort by
Journal Articles

Aberrant PDGFRA Signalling Is Sustained by An Autocrine Loop in Peripheral T-Cell Lymphoma Not Otherwise Specified

Pier Paolo Piccaluga, Maura Rossi, Aurora Esposito, PierLuigi Tazzari, MD, Francesca Ricci, BS, Claudio Agostinelli, Simona Righi, Anna Gazzola, Philip Went, Francesco Alviano, Gian Paolo Bagnara, P.L. Zinzani, M.D., Stefano A. Pileri
Journal: Blood
Blood (2008) 112 (11): 5331.
https://doi.org/10.1182/blood.V112.11.5331.5331
Published: 2008
Journal Articles

90 y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group

A. M. Carella, S. Nati, G. Fraternali Orcioni, M. Petrini, S. Galimberti, U. Vitolo, N. Cascavilla, P.L. Zinzani
Journal: Blood
Blood (2008) 112 (11): 3061.
https://doi.org/10.1182/blood.V112.11.3061.3061
Published: 2008
Journal Articles

Radioimmunotherapy Is Safe and Effective in Relapse after Stem Cell Transplantation for B- Cell Non Hodgkins Lymphoma, An Analysis of the International RIT-Network

Karin Hohloch, MD, P.L. Zinzani, M.D., Werner Linkesch, Jr., Andrzej Deptala, MD, PhD, Jurczak Wojciech, Cheolwon Suh, Michael Lorsbach, Christiane Windemuth-Kiesselbach, Lorenz H. Truemper
Journal: Blood
Blood (2008) 112 (11): 3064.
https://doi.org/10.1182/blood.V112.11.3064.3064
Published: 2008
Journal Articles

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

F. Morschhauser, D. Huglo, G. Martinelli, G. Paganelli, P.L. Zinzani, D. Hadjiyiannakis, A. Liberati, T. Illidge, N. Milpied, H. Stein, J. Kalmus, P. Morel, U. Reimann, R. Marcus
Journal: Blood
Blood (2004) 104 (11): 130.
https://doi.org/10.1182/blood.V104.11.130.130
Published: 2004